📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro. (2014)

First Author: Pang LY

Attributed to: Characterisation of primitive stem cell-like canine cancer cells: identification of therapeutic targets through genomics funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12917-014-0184-9

PubMed Identifier: 25190452

Publication URI: http://europepmc.org/abstract/MED/25190452

Type: Journal Article/Review

Volume: 10

Parent Publication: BMC veterinary research

ISSN: 1746-6148